Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
43.59%
↑ 301% above average
Average (39q)
-21.71%
Historical baseline
Range
High:246.91%
Low:-641.45%
CAGR
+2.5%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 43.59% |
| Q2 2025 | -62.50% |
| Q1 2025 | 27.27% |
| Q4 2024 | 31.25% |
| Q3 2024 | 9.43% |
| Q2 2024 | -130.43% |
| Q1 2024 | 82.58% |
| Q4 2023 | 4.35% |
| Q3 2023 | 2.47% |
| Q2 2023 | 47.00% |
| Q1 2023 | -65.84% |
| Q4 2022 | 63.33% |
| Q3 2022 | 16.70% |
| Q2 2022 | -63.92% |
| Q1 2022 | 35.89% |
| Q4 2021 | 4.48% |
| Q3 2021 | -8.92% |
| Q2 2021 | 31.14% |
| Q1 2021 | -8.86% |
| Q4 2020 | 69.15% |
| Q3 2020 | 8.17% |
| Q2 2020 | -36.05% |
| Q1 2020 | 2.00% |
| Q4 2019 | -49.93% |
| Q3 2019 | 22.09% |
| Q2 2019 | 13.78% |
| Q1 2019 | -165.35% |
| Q4 2018 | -19.80% |
| Q3 2018 | 246.91% |
| Q2 2018 | 17.03% |
| Q1 2018 | -9.29% |
| Q4 2017 | 26.21% |
| Q3 2017 | -35.66% |
| Q2 2017 | -580.31% |
| Q1 2017 | 91.56% |
| Q4 2016 | -641.45% |
| Q3 2016 | 110.48% |
| Q2 2016 | -68.70% |
| Q1 2016 | 55.31% |
| Q4 2015 | 16.38% |